Today, shares of Eupraxia Pharmaceuticals Inc opened at $4.00 and closed at $3.96. It traded at a low of $3.95 to a high of $4.12.

The price dipped -1.98 percent from the previous day's close of $4.04.

Today across North America, the TSX Composite closed tsx_percentage_change% at 22011.72, the S&P 500 closed sp_500_percentage_change% at 5010.60, the Dow Jones Industrial Average closed dow_jones_percentage_change% at 38239.98 and the Nasdaq Composite closed nasdaq_percentage_change% at 15451.31.

Eupraxia Pharmaceuticals Inc traded under EPRX on the Toronto Stock Exchange (TSX).

A total of 32,606 shares was traded during the session, with total trades of 61. On average, Eupraxia Pharmaceuticals Inc has traded 67,927 shares in the last five days and 57,081 year-to-date.

The TSX overall saw 3,894 price advancers against 1,317 declines and 99 unchanged.

During the prior 52 weeks, EPRX.TO has traded as high as $9.10 (July 05,2023) and low as $3.44 (April 18,2024). Moreover, in the last 12 months, Eupraxia Pharmaceuticals Inc's shares have shrunken -31.49%, while this year, they have shrunken -26.26%.

Following today's trading, Eupraxia Pharmaceuticals Inc has a market capitalization of $143.91 million on a float of 35,623 shares outstanding. Its annual EPS is $-1.17.

Eupraxia Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Victoria, CAN.

Eupraxia Pharmaceuticals Inc's average recommendation is "Strong Sell" based on 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..